Diaceutics PLC (AIM:DXRX)

Diaceutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118	106	73	64	86	112
Market Cap Growth	44.66%	44.66%	15.14%	-25.74%	-23.60%	58.13%
Enterprise Value	107	90	57	45	62	83
Last Close Price	1.40	1.25	0.87	0.76	1.02	1.33
PE Ratio	-	-	-	87.95	152.85	426.74
Forward PE	114.94	-	-	30.32	109.74	109.74
PS Ratio	3.68	3.30	3.09	3.27	6.15	8.84
PB Ratio	2.97	2.66	1.80	1.50	2.11	2.79
P/TBV Ratio	4.85	4.34	2.87	2.32	3.06	3.59
P/FCF Ratio	214.98	192.50	61.82	12.97	17150.06	967.52
P/OCF Ratio	181.96	162.93	55.93	12.50	150.44	443.61
EV/Sales Ratio	3.32	2.81	2.39	2.29	4.46	6.50
EV/EBITDA Ratio	151.23	163.86	555.87	21.53	40.96	194.30
EV/EBIT Ratio	-	-	-	77.74	112.96	-
EV/FCF Ratio	193.78	164.16	47.81	9.10	12425.86	711.89
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.00
Debt / EBITDA Ratio	1.50	1.50	4.73	0.60	1.00	0.28
Debt / FCF Ratio	1.92	1.92	1.02	0.27	312.20	1.02
Asset Turnover	0.68	0.68	0.50	0.42	0.32	0.39
Quick Ratio	3.66	3.66	6.11	8.07	11.24	11.33
Current Ratio	3.80	3.80	6.40	8.24	11.41	11.53
Return on Equity (ROE)	-4.22%	-4.22%	-4.19%	1.74%	1.39%	0.87%
Return on Assets (ROA)	-3.23%	-3.23%	-3.99%	0.77%	0.78%	-0.51%
Return on Capital (ROIC)	-3.70%	-3.70%	-4.40%	0.83%	0.83%	-0.56%
Return on Capital Employed (ROCE)	-	-	-	1.30%	1.30%	-
Earnings Yield	-1.44%	-1.61%	-2.38%	1.14%	0.65%	0.23%
FCF Yield	0.47%	0.52%	1.62%	7.71%	0.01%	0.10%
Buyback Yield / Dilution	-0.27%	-0.27%	2.16%	-1.35%	-9.14%	-21.29%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.